The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Cellular and molecular mechanisms of asthma and COPD
Abstract
Asthma and chronic obstructive pulmonary disease (COPD) both cause airway obstruction and are associated with chronic inflammation of the airways. However, the nature and sites of the inflammation differ between these diseases, resulting in different pathology, clinical manifestations and response to therapy. In this review, the inflammatory and cellular mechanisms of asthma and COPD are compared and the differences in inflammatory cells and profile of inflammatory mediators are highlighted. These differences account for the differences in clinical manifestations of asthma and COPD and their response to therapy. Although asthma and COPD are usually distinct, there are some patients who show an overlap of features, which may be explained by the coincidence of two common diseases or distinct phenotypes of each disease. It is important to better understand the underlying cellular and molecular mechanisms of asthma and COPD in order to develop new treatments in areas of unmet need, such as severe asthma, curative therapy for asthma and effective anti-inflammatory treatments for COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Malhotra, D., Thimmulappa, R., Navas-Acien, A., Sandford, A., Elliott, M., Singh, A., Chen, L., Zhuang, X., Hogg, J., Pare, P., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-380oc · Cited by 357
RetractedLozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
Gan, W. Q. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,838
Leckie, M. J., Brinke, A. T., Khan, J., Diamant, Z., O'Connor, B. J., Walls, C. M., Mathur, A. K., Cowley, H. C., Chung, K. F., Djukanovic, R., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03496-6 · Cited by 1,814
Self-citationIgE and mast cells in allergic disease
Galli, S. J., & Tsai, M. (2012) · Nature Medicine · doi:10.1038/nm.2755 · Cited by 1,799
Airway Mucus Function and Dysfunction
Fahy, J. V., & Dickey, B. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0910061 · Cited by 1,722
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
Barnes, P. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.011 · Cited by 1,683
Self-citationLambrecht, B. N., & Hammad, H. (2015) · Nature Immunology · doi:10.1038/ni.3049 · Cited by 1,673
The biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634
Immunology of asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2254 · Cited by 1,399
Self-citationMolecular mechanisms regulating NLRP3 inflammasome activation
Jo, E.-K., Kim, J. K., Shin, D.-M., & Sasakawa, C. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.95 · Cited by 1,378
Chronic obstructive pulmonary disease in non-smokers
Salvi, S. S., & Barnes, P. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61303-9 · Cited by 1,368
Self-citationLung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Lange, P., Celli, B., Agustí, A., Boje Jensen, G., Divo, M., Faner, R., Guerra, S., Marott, J. L., Martinez, F. D., Martinez-Camblor, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411532 · Cited by 1,284
Mast-Cell Infiltration of Airway Smooth Muscle in Asthma
Brightling, C. E., Bradding, P., Symon, F. A., Holgate, S. T., Wardlaw, A. J., & Pavord, I. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012705 · Cited by 1,241
Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease
McDonough, J. E., Yuan, R., Suzuki, M., Seyednejad, N., Elliott, W. M., Sanchez, P. G., Wright, A. C., Gefter, W. B., Litzky, L., Coxson, H. O., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106955 · Cited by 1,207
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
Lötvall, J., Akdis, C. A., Bacharier, L. B., Bjermer, L., Casale, T. B., Custovic, A., Lemanske, R. F., Wardlaw, A. J., Wenzel, S. E., & Greenberger, P. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.037 · Cited by 1,160
Eosinophils: changing perspectives in health and disease
Rosenberg, H. F., Dyer, K. D., & Foster, P. S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3341 · Cited by 989
The cytokine network in asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36130 · Cited by 982
Self-citationMaresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908
Cellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855
Agustí, A., Edwards, L. D., Rennard, S. I., MacNee, W., Tal-Singer, R., Miller, B. E., Vestbo, J., Lomas, D. A., Calverley, P. M. A., Wouters, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037483 · Cited by 848
Barrier Epithelial Cells and the Control of Type 2 Immunity
Hammad, H., & Lambrecht, B. N. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.007 · Cited by 847
Galbán, C. J., Han, M. K., Boes, J. L., Chughtai, K. A., Meyer, C. R., Johnson, T. D., Galbán, S., Rehemtulla, A., Kazerooni, E. A., Martinez, F. J., et al. (2012) · Nature Medicine · doi:10.1038/nm.2971 · Cited by 813
The prevalence of severe refractory asthma
Hekking, P.-P. W., Wener, R. R., Amelink, M., Zwinderman, A. H., Bouvy, M. L., & Bel, E. H. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.042 · Cited by 813
CD8 + T-Lymphocytes in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease
SAETTA, M., Di STEFANO, A., TURATO, G., FACCHINI, F. M., CORBINO, L., MAPP, C. E., MAESTRELLI, P., CIACCIA, A., & FABBRI, L. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9709027 · Cited by 792
New insights into the immunology of chronic obstructive pulmonary disease
Brusselle, G. G., Joos, G. F., & Bracke, K. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60988-4 · Cited by 776
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation
Franklin, B. S., Bossaller, L., De Nardo, D., Ratter, J. M., Stutz, A., Engels, G., Brenker, C., Nordhoff, M., Mirandola, S. R., Al-Amoudi, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2913 · Cited by 773
New developments in mast cell biology
Kalesnikoff, J., & Galli, S. J. (2008) · Nature Immunology · doi:10.1038/ni.f.216 · Cited by 748
Chronic obstructive pulmonary disease
Barnes, P. J., Burney, P. G. J., Silverman, E. K., Celli, B. R., Vestbo, J., Wedzicha, J. A., & Wouters, E. F. M. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.76 · Cited by 734
Self-citationCorticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 694
Self-citationKirkham, P. A., & Barnes, P. J. (2013) · Chest · doi:10.1378/chest.12-2664 · Cited by 685
Self-citationTH17-associated cytokines (IL-17A and IL-17F) in severe asthma
Al-Ramli, W., Préfontaine, D., Chouiali, F., Martin, J. G., Olivenstein, R., Lemière, C., & Hamid, Q. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.024 · Cited by 637
Price, D., Fletcher, M., & van der Molen, T. (2014) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2014.9 · Cited by 554
Increased 8-Isoprostane, a Marker of Oxidative Stress, in Exhaled Condensate of Asthma Patients
MONTUSCHI, P., CORRADI, M., CIABATTONI, G., NIGHTINGALE, J., KHARITONOV, S. A., & BARNES, P. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9809140 · Cited by 551
Self-citationMONTUSCHI, P., COLLINS, J. V., CIABATTONI, G., LAZZERI, N., CORRADI, M., KHARITONOV, S. A., & BARNES, P. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.2001063 · Cited by 548
Self-citationThe Asthma–COPD Overlap Syndrome
Postma, D. S., & Rabe, K. F. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1411863 · Cited by 548
Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.10.004 · Cited by 488
Self-citationAbdulqawi, R., Dockry, R., Holt, K., Layton, G., McCarthy, B. G., Ford, A. P., & Smith, J. A. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61255-1 · Cited by 487
Grumelli, S., Corry, D. B., Song, L.-Z., Song, L., Green, L., Huh, J., Hacken, J., Espada, R., Bag, R., Lewis, D. E., et al. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010008 · Cited by 484
Brusselle, G. G., VanderStichele, C., Jordens, P., Deman, R., Slabbynck, H., Ringoet, V., Verleden, G., Demedts, I. K., Verhamme, K., Delporte, A., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202698 · Cited by 477
Early-Life Origins of Chronic Obstructive Pulmonary Disease
Martinez, F. D. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1603287 · Cited by 473
AARON, S. D., ANGEL, J. B., LUNAU, M., WRIGHT, K., FEX, C., LE SAUX, N., & DALES, R. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2003122 · Cited by 466
Smith, S. G., Chen, R., Kjarsgaard, M., Huang, C., Oliveria, J.-P., O'Byrne, P. M., Gauvreau, G. M., Boulet, L.-P., Lemiere, C., Martin, J., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.037 · Cited by 459
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-506oc · Cited by 454
Russell, R. E. K., Culpitt, S. V., DeMatos, C., Donnelly, L., Smith, M., Wiggins, J., & Barnes, P. J. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.5.4685 · Cited by 448
Self-citationHodge, S., Hodge, G., Scicchitano, R., Reynolds, P. N., & Holmes, M. (2003) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2003.t01-1-01170.x · Cited by 440
The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease
Rennard, S. I., Fogarty, C., Kelsen, S., Long, W., Ramsdell, J., Allison, J., Mahler, D., Saadeh, C., Siler, T., Snell, P., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-995oc · Cited by 439
The Cytokine Network in Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0220tr · Cited by 412
Self-citationKeatings, V. M., & Barnes, P. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032177 · Cited by 402
Self-citationYing, S., O’Connor, B., Ratoff, J., Meng, Q., Fang, C., Cousins, D., Zhang, G., Gu, S., Gao, Z., Shamji, B., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2790 · Cited by 402
The receptor NLRP3 is a transcriptional regulator of TH2 differentiation
Bruchard, M., Rebé, C., Derangère, V., Togbé, D., Ryffel, B., Boidot, R., Humblin, E., Hamman, A., Chalmin, F., Berger, H., et al. (2015) · Nature Immunology · doi:10.1038/ni.3202 · Cited by 395
New anti-inflammatory targets for chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4025 · Cited by 392
Self-citationIncreased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD
Traves, S. L. (2002) · Thorax · doi:10.1136/thorax.57.7.590 · Cited by 377
Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema
Majo, J., Ghezzo, H., & Cosio, M. G. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17509460 · Cited by 374
Saetta, M., Mariani, M., Panina-Bordignon, P., Turato, G., Buonsanti, C., Baraldo, S., Bellettato, C. M., Papi, A., Corbetta, L., Zuin, R., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107139 · Cited by 372
Smoking and asthma: dangerous liaisons
Polosa, R., & Thomson, N. C. (2013) · European Respiratory Journal · doi:10.1183/09031936.00073312 · Cited by 370
Pathophysiology of allergic inflammation
Barnes, P. J. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01020.x · Cited by 361
Self-citationAlveolar Macrophages as Orchestrators of COPD
Barnes, P. J. (2004) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-120028701 · Cited by 360
Self-citationDefective macrophage phagocytosis of bacteria in COPD
Taylor, A. E., Finney-Hayward, T. K., Quint, J. K., Thomas, C. M. R., Tudhope, S. J., Wedzicha, J. A., Barnes, P. J., & Donnelly, L. E. (2010) · European Respiratory Journal · doi:10.1183/09031936.00036709 · Cited by 359
Self-citationClinical COPD phenotypes: a novel approach using principal component and cluster analyses
Burgel, P.-R., Paillasseur, J.-L., Caillaud, D., Tillie-Leblond, I., Chanez, P., Escamilla, R., Court-Fortune, I., Perez, T., Carré, P., & Roche, N. (2010) · European Respiratory Journal · doi:10.1183/09031936.00175109 · Cited by 358
Long-term IL-33–producing epithelial progenitor cells in chronic obstructive lung disease
Byers, D. E., Alexander-Brett, J., Patel, A. C., Agapov, E., Dang-Vu, G., Jin, X., Wu, K., You, Y., Alevy, Y., Girard, J.-P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65570 · Cited by 337
Di Stefano, A., Caramori, G., Gnemmi, I., Contoli, M., Vicari, C., Capelli, A., Magno, F., D'Anna, S. E., Zanini, A., Brun, P., et al. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03965.x · Cited by 336
Self-citationAccelerated ageing of the lung in COPD: new concepts
Mercado, N., Ito, K., & Barnes, P. J. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206084 · Cited by 334
Self-citationCulpitt, S. V., Rogers, D. F., Shah, P., De Matos, C., Russell, R. E. K., Donnelly, L. E., & Barnes, P. J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-298oc · Cited by 333
Self-citationBlood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
Pavord, I. D., Lettis, S., Locantore, N., Pascoe, S., Jones, P. W., Wedzicha, J. A., & Barnes, N. C. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207021 · Cited by 327
Gaggar, A., Jackson, P. L., Noerager, B. D., O’Reilly, P. J., McQuaid, D. B., Rowe, S. M., Clancy, J. P., & Blalock, J. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5662 · Cited by 325
Mechanisms of Airway Remodeling
Hirota, N., & Martin, J. G. (2013) · Chest · doi:10.1378/chest.12-3073 · Cited by 324
Role of HDAC2 in the Pathophysiology of COPD
Barnes, P. J. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163257 · Cited by 318
Self-citationAntagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases
Pettipher, R., Hansel, T. T., & Armer, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2266 · Cited by 317
de BOER, W. I., van SCHADEWIJK, A., SONT, J. K., SHARMA, H. S., STOLK, J., HIEMSTRA, P. S., & van KRIEKEN, J. H. J. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9803053 · Cited by 314
Russell, R. E. K., Thorley, A., Culpitt, S. V., Dodd, S., Donnelly, L. E., Demattos, C., Fitzgerald, M., & Barnes, P. J. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00020.2002 · Cited by 296
Self-citationExhaled leukotrienes and prostaglandins in COPD
Montuschi, P. (2003) · Thorax · doi:10.1136/thorax.58.7.585 · Cited by 293
Stem cell factor and its receptor c-Kit as targets for inflammatory diseases
Reber, L., Da Silva, C. A., & Frossard, N. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.067 · Cited by 280
Biernacki, W. A. (2003) · Thorax · doi:10.1136/thorax.58.4.294 · Cited by 276
Senescence in COPD and Its Comorbidities
Barnes, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034314 · Cited by 266
Self-citationCXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease
Rennard, S. I., Dale, D. C., Donohue, J. F., Kanniess, F., Magnussen, H., Sutherland, E. R., Watz, H., Lu, S., Stryszak, P., Rosenberg, E., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201405-0992oc · Cited by 261
Targeting the interleukin pathway in the treatment of asthma
Chung, K. F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00157-9 · Cited by 261
Takhar, P., Corrigan, C. J., Smurthwaite, L., O'Connor, B. J., Durham, S. R., Lee, T. H., & Gould, H. J. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.09.045 · Cited by 258
Increased activation of p38 MAPK in COPD
Renda, T., Baraldo, S., Pelaia, G., Bazzan, E., Turato, G., Papi, A., Maestrelli, P., Maselli, R., Vatrella, A., Fabbri, L. M., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00036707 · Cited by 257
Burgel, P.-R. (2004) · Thorax · doi:10.1136/thx.2003.018879 · Cited by 251
Role of alveolar macrophages in chronic obstructive pulmonary disease
Vlahos, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00435 · Cited by 247
Gonem, S., Berair, R., Singapuri, A., Hartley, R., Laurencin, M. F. M., Bacher, G., Holzhauer, B., Bourne, M., Mistry, V., Pavord, I. D., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30179-5 · Cited by 247
Inflammatory Biomarkers and Comorbidities in Chronic Obstructive Pulmonary Disease
Thomsen, M., Dahl, M., Lange, P., Vestbo, J., & Nordestgaard, B. G. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-1113oc · Cited by 245
Gao, W., Li, L., Wang, Y., Zhang, S., Adcock, I. M., Barnes, P. J., Huang, M., & Yao, X. (2015) · Respirology · doi:10.1111/resp.12542 · Cited by 239
Self-citationNeutrophil Chemotactic Activity of Sputum From Patients With COPD
Beeh, K. M., Kornmann, O., Buhl, R., Culpitt, S. V., Giembycz, M. A., & Barnes, P. J. (2003) · Chest · doi:10.1378/chest.123.4.1240 · Cited by 233
Self-citationDi Stefano, A., Maestrelli, P., Roggeri, A., Turato, G., Calabro, S., Potena, A., Mapp, C. E., Ciaccia, A., Covacev, L., & Fabbri, L. M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.3.7509705 · Cited by 228
A protein deacetylase SIRT1 is a negative regulator of metalloproteinase‐9
Nakamaru, Y., Vuppusetty, C., Wada, H., Milne, J. C., Ito, M., Rossios, C., Elliot, M., Hogg, J., Kharitonov, S., Goto, H., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-125468 · Cited by 225
Self-citationElevation of Exhaled Ethane Concentration in Asthma
PAREDI, P., KHARITONOV, S. A., & BARNES, P. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.2003064 · Cited by 221
Self-citationRelationship of Epidermal Growth Factor Receptors to Goblet Cell Production in Human Bronchi
TAKEYAMA, K., FAHY, J. V., & NADEL, J. A. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2001038 · Cited by 219
Caramori, G. (2003) · Thorax · doi:10.1136/thorax.58.4.348 · Cited by 216
Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress
Mercado, N., Thimmulappa, R., Thomas, C. M. R., Fenwick, P. S., Chana, K. K., Donnelly, L. E., Biswal, S., Ito, K., & Barnes, P. J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.035 · Cited by 209
Self-citationCurrent concepts of severe asthma
Ray, A., Raundhal, M., Oriss, T. B., Ray, P., & Wenzel, S. E. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84144 · Cited by 207
Transient receptor potential (TRP) channels in the airway: role in airway disease
Grace, M. S., Baxter, M., Dubuis, E., Birrell, M. A., & Belvisi, M. G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12538 · Cited by 190
Defective Phagocytosis in Airways Disease
Donnelly, L. E., & Barnes, P. J. (2012) · Chest · doi:10.1378/chest.11-2348 · Cited by 190
Self-citationKirkham, P. A., Caramori, G., Casolari, P., Papi, A. A., Edwards, M., Shamji, B., Triantaphyllopoulos, K., Hussain, F., Pinart, M., Khan, Y., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1605oc · Cited by 186
Self-citationCastaldi, P. J., Dy, J., Ross, J., Chang, Y., Washko, G. R., Curran-Everett, D., Williams, A., Lynch, D. A., Make, B. J., Crapo, J. D., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-203601 · Cited by 182
Sapey, E., Stockley, J. A., Greenwood, H., Ahmad, A., Bayley, D., Lord, J. M., Insall, R. H., & Stockley, R. A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201008-1285oc · Cited by 175
The asthma–COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?
Bateman, E. D., Reddel, H. K., van Zyl-Smit, R. N., & Agusti, A. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00254-4 · Cited by 175
Characterization and Quantification of Innate Lymphoid Cell Subsets in Human Lung
De Grove, K. C., Provoost, S., Verhamme, F. M., Bracke, K. R., Joos, G. F., Maes, T., & Brusselle, G. G. (2016) · PLOS ONE · doi:10.1371/journal.pone.0145961 · Cited by 170
Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2
Traves, S. L., Smith, S. J., Barnes, P. J., & Donnelly, L. E. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003495 · Cited by 169
Self-citationTherapeutic approaches to asthma–chronic obstructive pulmonary disease overlap syndromes
Barnes, P. J. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.052 · Cited by 165
Self-citationCXCR3 and CCR5 Chemokines in Induced Sputum From Patients With COPD
Costa, C., Rufino, R., Traves, S. L., Lapa e Silva, J. R., Barnes, P. J., & Donnelly, L. E. (2008) · Chest · doi:10.1378/chest.07-0393 · Cited by 165
Self-citationThe heterogeneity of lung macrophages in the susceptibility to disease
Morales-Nebreda, L., Misharin, A. V., Perlman, H., & Budinger, G. R. S. (2015) · European Respiratory Review · doi:10.1183/16000617.0031-2015 · Cited by 162
Th9 and other IL-9-producing cells in allergic asthma
Koch, S., Sopel, N., & Finotto, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-016-0601-1 · Cited by 160
Mast cell proteases as pharmacological targets
Caughey, G. H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.045 · Cited by 157
Increased IL-33 expression in chronic obstructive pulmonary disease
Xia, J., Zhao, J., Shang, J., Li, M., Zeng, Z., Zhao, J., Wang, J., Xu, Y., & Xie, J. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00305.2014 · Cited by 153
Type 2 innate lymphoid cells: new players in asthma and allergy
Scanlon, S. T., & McKenzie, A. N. J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.08.009 · Cited by 151
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Stefano, A. D., Caramori, G., Capelli, A., Gnemmi, I., Ricciardolo, F. L. M., Oates, T. M., Donner, C. F., Chung, K. F., Barnes, P. J., & Adcock, I. M. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00080303 · Cited by 144
Self-citationXu, X., Jackson, P. L., Tanner, S. M., Hardison, M. T., Roda, M. A., Blalock, J. E., & Gaggar, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015781 · Cited by 139
Inflammasomes in COPD and neutrophilic asthma
Kim, R., Pinkerton, J., Gibson, P. G., Cooper, M. A., Horvat, J. C., & Hansbro, P. M. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206736 · Cited by 133
Lee, S., Suh, G. Y., Ryter, S. W., & Choi, A. M. K. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0231tr · Cited by 130
Bittar, H. E. T., Yousem, S. A., & Wenzel, S. E. (2014) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040343 · Cited by 128
Role of B Cell–Activating Factor in Chronic Obstructive Pulmonary Disease
Seys, L., Verhamme, F. M., Schinwald, A., Hammad, H., Cunoosamy, D. M., Bantsimba-Malanda, C., Sabirsh, A., McCall, E. J., Flavell, L., Herbst, R., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0103oc · Cited by 125
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
Stefano, A. D., Caramori, G., Barczyk, A., Vicari, C., Brun, P., Zanini, A., Cappello, F., Garofano, E., Padovani, A., Contoli, M., et al. (2013) · European Respiratory Journal · doi:10.1136/thoraxjnl-2012-203062 · Cited by 123
Self-citationFreeman, C. M., Martínez, F. J., Han, M. K., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200904-0552oc · Cited by 121
Alternative mechanisms for tiotropium
Bateman, E. D., Rennard, S. I., Barnes, P. J., Dicpinigaitis, P. V., Gosens, R., Gross, N. J., Nadel, J. A., Pfeifer, M. A., Racké, K., Rabe, K. F., et al. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2009.06.002 · Cited by 117
Self-citationBiologics and the lung: TSLP and other epithelial cell-derived cytokines in asthma
Mitchell, P. D., & O’Byrne, P. M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.009 · Cited by 116
Impaired macrophage phagocytosis of bacteria in severe asthma
Liang, Z., Zhang, Q., Thomas, C. M. R., Chana, K. K., Gibeon, D. S., Barnes, P. J., Chung, K. F., Bhavsar, P. K., & Donnelly, L. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-72 · Cited by 115
Self-citationKinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012518 · Cited by 115
Self-citationVlahos, R., Bozinovski, S., Chan, S. P. J., Ivanov, S., Lindén, A., Hamilton, J. A., & Anderson, G. P. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1794oc · Cited by 114
Mitani, A., Ito, K., Vuppusetty, C., Barnes, P. J., & Mercado, N. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201503-0593oc · Cited by 111
Self-citationAssessing and treating small airways disease in asthma and chronic obstructive pulmonary disease
Usmani, O. S., & Barnes, P. J. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.585656 · Cited by 107
Self-citationNew Therapies for Asthma and Chronic Obstructive Pulmonary Disease
Gross, N. J., & Barnes, P. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2074pp · Cited by 107
Self-citationSelective accumulation of langerhans-type dendritic cells in small airways of patients with COPD
Pottelberge, G. R. V., Bracke, K. R., Demedts, I., Rijck, K. D., Reinartz, S. M., van Drunen, C. M., Verleden, G. M., Vermassen, F. E. G., Joos, G., & Brusselle, G. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-35 · Cited by 94
The airway vasculature: recent advances and clinical implications
Paredi, P., & Barnes, P. J. (2009) · Thorax · doi:10.1136/thx.2008.100032 · Cited by 93
Self-citationEmergence of Biomolecular Pathways to Define Novel Asthma Phenotypes. Type-2 Immunity and Beyond
Wenzel, S. E. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0141ps · Cited by 86
T Helper 17 Cells in Airway Diseases
Halwani, R., Al‐Muhsen, S., & Hamid, Q. A. (2013) · CHEST Journal · doi:10.1378/chest.12-0598 · Cited by 85
Obesity and Asthma: Microbiome–Metabolome Interactions
Shore, S. A., & Cho, Y. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0052ps · Cited by 85
Hodge, G. L., Mukaro, V. R., Reynolds, P. N., & Hodge, S. J. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04455.x · Cited by 81
Canakinumab for the treatment of chronic obstructive pulmonary disease
Rogliani, P., Calzetta, L., Ora, J., & Matera, M. G. (2015) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2015.01.005 · Cited by 80
Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD
da Costa, C. H., Traves, S. L., Tudhope, S. J., Fenwick, P. S., Belchamber, K. B. R., Russell, R. E. K., Barnes, P. J., & Donnelly, L. (2016) · European Respiratory Journal · doi:10.1183/13993003.01642-2015 · Cited by 79
Self-citationSingh, R., Mackay, A. J., Patel, A. R. C., Garcha, D. S., Kowlessar, B. S., Brill, S., Donnelly, L., Barnes, P. J., Donaldson, G. C., & Wedzicha, J. A. (2014) · Respiratory Research · doi:10.1186/s12931-014-0114-1 · Cited by 78
Self-citationLambers, C., Hacker, S., Posch, M., Höetzenecker, K., Pollreisz, A., Lichtenauer, M., Klepetko, W., & Ankersmit, H. J. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03835.x · Cited by 76
Airway Smooth Muscle in Asthma
Black, J. L., Panettieri, R. A., Banerjee, A., & Berger, P. (2012) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2012.05.002 · Cited by 73
Chana, K. K., Fenwick, P. S., Nicholson, A. G., Barnes, P. J., & Donnelly, L. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.08.044 · Cited by 68
Self-citationThe Many Faces of Asthma in Obesity
Sideleva, O., & Dixon, A. E. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24678 · Cited by 67
Antiendothelial Cell Antibodies in Patients With COPD
Karayama, M., Inui, N., Suda, T., Nakamura, Y., Nakamura, H., & Chida, K. (2010) · CHEST Journal · doi:10.1378/chest.10-0863 · Cited by 59
Nerve growth factor: The central hub in the development of allergic asthma?
Nassenstein, C., Schulte‐Herbrüggen, O., Renz, H. E., & Braun, A. C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.061 · Cited by 58
Bafadhel, M., Saha, S., Siva, R., McCormick, M., Monteiro, W. R., Rugman, P., Dodson, P., Pavord, I. D., Newbold, P., & Brightling, C. E. (2009) · Respiration · doi:10.1159/000221902 · Cited by 58
Nahm, D., Lee, Y. E., Yim, E.-J., Park, H., Yim, H., KANG, Y. Y., & Kim, J.-K. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200201-009oc · Cited by 57
Regulation of IL-17 in chronic inflammation in the human lung
Pridgeon, C., Bugeon, L., Donnelly, L., Straschil, U., Tudhope, S. J., Fenwick, P. S., Lamb, J. R., Barnes, P. J., & Dallman, M. J. (2011) · Clinical Science · doi:10.1042/cs20100417 · Cited by 55
Self-citationDendritic Cells in Pathogenesis of COPD
Givi, M. E., Redegeld, F. A., Folkerts, G., & Mortaz, E. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800166068 · Cited by 47
Kato, A., Xiao, H., Chustz, R. T., Liu, M. C., & Schleimer, R. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.11.022 · Cited by 46
New Developments in Mast Cell Biology
Arthur, G. K., & Bradding, P. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.06.009 · Cited by 42
Dendritic Cells in Human Lung Disease
Upham, J. W., & Xi, Y. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.09.030 · Cited by 40
Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far?
Parulekar, A. D., Diamant, Z., & Hanania, N. A. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000343 · Cited by 32
Chronic Obstructive Pulmonary Disease
Welte, T. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0825 · Cited by 15
Cited by
Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Zuo, L., Prather, E. R., Stetskiv, M., Garrison, D. E., Meade, J. R., Peace, T. I., & Zhou, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184472 · Cited by 539
Zhang, M., Ma, Y., Ye, X., Zhang, N., Pan, L., & Wang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01464-x · Cited by 522
Impact of Air Pollution on Asthma Outcomes
Tiotiu, A. I., Novakova, P., Nedeva, D., Chong-Neto, H. J., Novakova, S., Steiropoulos, P., & Kowal, K. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176212 · Cited by 513
Targeting cytokines to treat asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0006-6 · Cited by 418
Self-citationMokra, D., Joskova, M., & Mokry, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010340 · Cited by 355
Metadata
- Authors
- Barnes, P. J.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2017-06-28
- Volume
- 131
- Issue
- 13
- Pages
- 1541-1558
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2726572061
- Cited by
- 511
- References
- 150
- FWCI
- 27.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.